Deep Dive

Digital
Deep Dive Communications 2020

Deep Dive: Communications 2020

COVID-19 might have forced pharma to finally fully embrace digital comms, but it’s been a steep learning curve and expertise varies across the industry.

Views & Analysis
R&D Disruption

Deep Dive: R&D Disruption

With costs skyrocketing and return on investment plummeting, R&D arguably needs disruption more than any other area of the industry.

Views & Analysis
combined-digital-pharmaceutical-approach-to-diabetes-1200x675-Feature

Creating solutions, not products, in diabetes

Roche Diabetes Care’s Michael Goetzl explains how the company is spearheading a combined digital-pharmaceutical approach to diabetes and how pharma firms can best embrace holistic strategie

Views & Analysis
From-narrow-AI-to-broad-AI-1200x675-Feature

From narrow AI to broad AI

As director of global life sciences at IBM Watson Health, Christina Busmalis is well placed to know how AI is set to transform life sciences.